BioScience Health Innovations (BHIC) Equity Average (2020 - 2025)
Historic Equity Average for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to $1.7 million.
- BioScience Health Innovations' Equity Average rose 51332.19% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 51332.19%. This contributed to the annual value of $414240.0 for FY2024, which is 356021.8% up from last year.
- According to the latest figures from Q3 2025, BioScience Health Innovations' Equity Average is $1.7 million, which was up 51332.19% from $1.5 million recorded in Q2 2025.
- BioScience Health Innovations' 5-year Equity Average high stood at $1.7 million for Q3 2025, and its period low was -$71621.0 during Q2 2023.
- Moreover, its 5-year median value for Equity Average was $30163.5 (2021), whereas its average is $282019.7.
- In the last 5 years, BioScience Health Innovations' Equity Average crashed by 64020.73% in 2021 and then surged by 6534641.69% in 2024.
- Quarter analysis of 5 years shows BioScience Health Innovations' Equity Average stood at $30163.5 in 2021, then crashed by 33.91% to $19934.5 in 2022, then plummeted by 95.38% to $921.0 in 2023, then soared by 65346.42% to $602761.5 in 2024, then skyrocketed by 184.58% to $1.7 million in 2025.
- Its last three reported values are $1.7 million in Q3 2025, $1.5 million for Q2 2025, and $1.0 million during Q1 2025.